Livongo Health

By Dave Muoio June 28, 2019
Months after the first rumors began to swirl, chronic disease management startup Livongo Health has officially filed for an IPO on the Nasdaq Global Select Market. The company has not yet determined a price range or the number of shares going on offer. Morgan Stanley & Co., Goldman Sachs & Co. and JP Morgan Securities will serve as the lead book runners. Sources close to Livongo told...
By Dave Muoio June 26, 2019
Digital chronic disease management startup Livongo is making the jump from patients’ pockets to their wrists with new integrations that will bring some of the mobile app’s alerts and features to consumer smartwatches. Starting today, certain models of Apple Watches, Fitbits and Samsung Gear wearables will surface individualized “Health Nudges” that encourage the wearer to perform certain...
By Jonah Comstock March 7, 2019
It's been a while since the digital health space has seen an IPO. But that's about to change, according to The Wall Street Journal, which reports that chronic disease management startup Livongo Health is planning to go public this year.  According to the Journal, the company has hired Morgan Stanley, Goldman Sachs and JPMorgan Chase as underwriters, and is looking towards a valuation over $1...
By Dave Muoio January 17, 2019
Dr. Bimal Shah and Courtnee Westendorf have been announced as the chief medical officer and chief marketing officer, respectively, of Livongo Health. Shah was promoted internally from a position of SVP of clinical strategy, while Westendorf previously served as the chief marketing officer of the Oakland Raiders football team. “We are excited to have a leading marketing executive like Courtnee...
By Jonah Comstock November 14, 2018
Diabetes management company Virta Health announced today that the company will offer its service to employers and health plans at 100 percent risk — that is, customers will only pay if the company succeeds in its goal of reversing Type 2 diabetes and getting patients off of expensive diabetes medications. “Whoever pays the healthcare bill today, we say to them, 'Wouldn’t it be awesome if we could...
By Dave Muoio June 25, 2018
This weekend saw the kickoff of the American Diabetes Association’s 78th annual conference, and with it a slew of new data from diabetes management players. The meeting included presentation on studies covering a range of technologies, such as continuous glucose monitors, insulin pumps, apps, and other digital-backed management strategies. Among the studies highlighted by the association was an...
By Jonah Comstock March 16, 2017
Technology-enabled diabetes management company Livongo Health has raised $52.5 million in new funding in a round co-led by General Catalyst, an existing investor, and international investment company Kinnevik. Other investors included Microsoft Ventures, American Investment Holdings, and EDBI, a Singapore-based fund whose portfolio includes WellTok, GoBalto, and Sotera Wireless. All previous...
By Heather Mack February 16, 2017
Chronic disease management company Livongo is collaborating with Voluntis, the Paris, France-based company that develops companion apps for medical devices, to offer an integrated program, insulin delivery system and app for people with type 2 diabetes. Members will have access to the Livongo for Diabetes Program with Voluntis’ Insulia, the diabetes management app that received both FDA approval...
By Heather Mack November 16, 2016
Mountain View, California-based Livongo Health, a chronic disease management company, has launched a new capability on its smart blood glucose meter. The device now employs one of the most basic – yet perhaps underrated – features of a smartphone: the ability to download over-the-air updates. The Livongo meter, a smart glucose meter that the company says is the first such device to offer...
By Jonah Comstock May 12, 2016
April was a big month for digital health funding, with 15 more deals coming through, totalling an impressive $220 million and bringing the total funding so far this year to $691 million. As we did in February with Oscar, we're excluding the largest deal, Bright Health's $80 million round, from the total because the company in question is a tech-saavy payer, but not a digital health company per se...